Tech Company Financing Transactions

Inato Funding Round

Inato secured a $20 million Series A funding round on 3/28/2023. Backers included Cathay Innovation, La Maison and Obvious Ventures.

Transaction Overview

Company Name
Announced On
3/28/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Proceeds Purpose
The company intends to use the new funding for continued product innovation, international growth, and hiring of talent. Inato will advance its diversity product offering to enable sponsors to strategically meet their diversity goals based on new FDA requirements, invest in oncology-specific innovation, further define and scale its data model to continue to improve matching reliability between community sites and sponsor trials.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 Village Walk 198
Guilford, CT 06437
USA
Phone
Undisclosed
Email Address
Overview
At Inato, our mission is to bring clinical research to each and every patient, regardless of who they are and where they live. We envision a world where participating in a trial is so simple that all doctors can offer the right trial for their patients. By enabling all community sites to offer the right trials to their patients, we will not only make clinical research more inclusive, but also more efficient.
Profile
Inato LinkedIn Company Profile
Social Media
Inato Company Twitter Account
Company News
Inato News
Facebook
Inato on Facebook
YouTube
Inato on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kourosh Davarpanah
  Kourosh Davarpanah LinkedIn Profile  Kourosh Davarpanah Twitter Account  Kourosh Davarpanah News  Kourosh Davarpanah on Facebook
Chief Medical Officer
Jean Zeitoun
   Jean Zeitoun LinkedIn Profile   Jean Zeitoun Twitter Account   Jean Zeitoun News   Jean Zeitoun on Facebook
Chief Scientific Officer
Liz Beatty
  Liz Beatty LinkedIn Profile  Liz Beatty Twitter Account  Liz Beatty News  Liz Beatty on Facebook
Chief Scientific Officer
Philippe Ravaud
  Philippe Ravaud LinkedIn Profile  Philippe Ravaud Twitter Account  Philippe Ravaud News  Philippe Ravaud on Facebook
Chief Technical Officer
Bastien Duret
  Bastien Duret LinkedIn Profile  Bastien Duret Twitter Account  Bastien Duret News  Bastien Duret on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/28/2023: Sirius Medical venture capital transaction
Next: 3/28/2023: EigenLayer venture capital transaction

 

Share this article

 


Where The Data Comes From

We document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary